References
- Siegel K, Lekas H-M. AIDS as a chronic illness: psychosocial implications. AIDS. 2002;16:S69–S76. http://journals.lww.com/aidsonline/Fulltext/2002/16004/AIDS_as_a_chronic_illness__psychosocial.10.aspx. Accessed February 3, 2017.10.1097/00002030-200216004-00010
- Epstein S. The construction of lay expertise: AIDS activism and the forging of credibility in the reform of clinical trials. Sci Technol Hum Values. 1995;20(4):408–437. http://sth.sagepub.com/content/20/4/408.short. Accessed February 3, 2017.10.1177/016224399502000402
- Barré-Sinoussi F, Ross AL, Delfraissy J-F. Past, present and future: 30 years of HIV research. Nat Rev Microbiol. 2013;11(12):877–883. doi:10.1038/nrmicro3132.
- Bayer R. Public health policy and the AIDS epidemic: An end to HIV exceptionalism? N Engl J Med. 1991;324(21):1500–1504. doi:10.1056/NEJM199105233242111.
- Molina J-M, Capitant C, Spire B, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–2246. doi:10.1056/NEJMoa1506273.
- Dabis F, Newell M-L, Hirschel B. HIV drugs for treatment, and for prevention. The Lancet. 2010;375(9731):2056–2057.10.1016/S0140-6736(10)60838-0
- Deeks SG, Autran B, Berkhout B, et al. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol. 2012;12(8):607–614. doi:10.1038/nri3262.
- Deeks SG, Barré-Sinoussi F. Public health: Towards a cure for HIV. Nature. 2012;487(7407):293–294. doi:10.1038/487293a.
- Tucker JD, Rennie S, the social and ethical working group on HIV cure. Social and ethical implications of HIV cure research. AIDS. 2014;28(9):1247–1250. doi:10.1097/QAD.0000000000000210.
- Préau M, Doumergue M, Spire B, et al. Perspectives on the acceptability of HCRC trials: the challenges for physicians and PLWHIV (ANRS APSEC). In: Keystone Symposia on Molecular and Cellular Biology: Mechanisms of HIV Persistence – Implications for a Cure. Boston, MA; 2015.
- Protière C, Lambotte O, Mora M, et al. HIV patients and caregivers viewpoints towards participation to future HIV Cure-related clinical trials – results from the second part of the French ANRS-APSEC survey. In: Toward an HIV Cure Symposium. Durban; 2016.
- Rosenbrock R, Dubois-Arber F, Moers M, Pinell P, Schaeffer D, Setbon M. The normalization of AIDS in Western European countries. Soc Sci Med. 2000;50(11):1607–1629. doi:10.1016/S0277-9536(99)00469-4.
- Moyer E, Hardon A. A disease unlike any other? Why HIV remains exceptional in the age of treatment. Med Anthropol. 2014;33(4):263–269. doi:10.1080/01459740.2014.890618.
- McGrath JW, Winchester MS, Kaawa-Mafigiri D, et al. Challenging the paradigm: anthropological perspectives on HIV as a chronic disease. Med Anthropol. 2014;33(4):303–317. doi:10.1080/01459740.2014.892483.
- Persson A, Race K, Wakeford E. HIV health in context: negotiating medical technology and lived experience. Health. 2003;7(4):397–415. http://journals.sagepub.com/doi/abs/10.1177/13634593030074002. Accessed February 3, 2017.
- Whiteside A, Smith J. Exceptional epidemics: AIDS still deserves a global response. Glob Health. 2009;5(1):15. doi:10.1186/1744-8603-5-15.